Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
NCT: NCT05467163 · ACTIVE_NOT_RECRUITING
Brief Summary
Atrioventricular node ablation (AVNA) with biventricular (BiV) pacemaker implantation is a feasible treatment option in patients with symptomatic refractory atrial fibrillation and heart failure. However, conduction system pacing (CSP) modalities, including His bundle pacing and left bundle branch pacing, could offer advantages over BiV pacing by providing more physiological activation. The randomized, interventional, multicentric study will explore whether CSP is non-inferior to BiV pacing in echocardiographic and clinical outcomes in heart failure (EF \<50%) patients with symptomatic AF and narrow QRS scheduled for AVNA.
Frequently Asked Questions
What is Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation?
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation is a clinical trial registered under NCT05467163. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05467163?
The current status of NCT05467163 (Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation) is: ACTIVE_NOT_RECRUITING.
When did Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation start?
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation started on 2023-07-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.